Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX

Objective. To examine the role of adenosine receptor 2a gene (ADORA2a) polymorphisms on outcome of MTX treatment in RA. Methods. Subjects included 309 RA patients with a defined response to MTX. Patients were included if they were (i) good responders (n = 147) (ESR <20 for >6/12 on stable dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Hider, S. L., Thomson, W., Mack, L. F., Armstrong, D. J., Shadforth, M., Bruce, I. N.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2468887/
https://www.ncbi.nlm.nih.gov/pubmed/18539621
http://dx.doi.org/10.1093/rheumatology/ken182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2468887/
https://www.ncbi.nlm.nih.gov/pubmed/18539621
http://dx.doi.org/10.1093/rheumatology/ken182

Ejemplares similares